Atyr PHARMA INC (NASDAQ:ATYR) Receives Average Rating of “Buy” from Brokerages
Atyr PHARMA INC (NASDAQ:ATYR – Get Free Report) has been assigned an average recommendation of “Buy” from the seven research firms that are presently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price […]
Atyr PHARMA INC (NASDAQ:ATYR – Get Free Report) has been assigned an average recommendation of “Buy” from the seven research firms that are presently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price […]
